1. |
阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)写作组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版). 中国呼吸与危重监护杂志, 2015, 14(4): 398-405.
|
2. |
Watson NF. Health care savings: the economic value of diagnostic and therape tic care for obstructive sleep apnea. J Clin Sleep Med, 2016, 12(8): 1075-1077.
|
3. |
Shi Q, Wang R, Zhang H, et al. Association between serum uric acid and cardiovascular disease risk factors in adolescents in America: 2001-2018. PLoS One, 2021, 16(8): e0254590.
|
4. |
Chen J. Serum Uric acid level and all-cause and cardiovascular mortality in Chinese elderly: a community-based cohort study in Shanghai. Nutr Metab Cardiovasc Dis, 2021, 31(12): 3367-3376.
|
5. |
Bartziokas K, Papaioannou AI, Haniotou A, et al. Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment. Postgrad Med, 2021, 133(5): 518-524.
|
6. |
Popadic V, Brajkovic M, Klasnja S, et al. Correlation of dyslipidemia and inflammation with obstructive sleep apnea severity. Front Pharmacol, 2022, 13: 897279.
|
7. |
Floras JS. Sleep apnea and cardiovascular disease an enigmatic risk factor. Circ Res, 2018, 122(12): 1741-1764.
|
8. |
王立曼, 周光耀, 刘亚峰, 等. 阻塞性睡眠呼吸暂停低通气综合征男女患者生物学特征分析. 中国呼吸与危重监护杂志, 2010, 9(5): 501-503.
|
9. |
Sunnetcioglu A, Sertogullarından B, Ozbay B, et al. Obstructive sleep apnea related to rapid -eyemovement or non-rapid-eye-movement sleep: comparison of demographic, anthropometric, and polysomnographic features. J Bras Pneumol, 2016, 42(1): 48-54.
|
10. |
Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000, 342(19): 1378-1384.
|
11. |
Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med, 2013, 1(1): 61-72.
|
12. |
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet, 2002, 359(9302): 204-210.
|
13. |
Bouloukaki I, Mermigkis C, Tzanakis N, et al. Evaluation of inflammatory markers in a large sample of obstructive sleep apnea patients without comorbidities. Mediators Inflamm, 2017, 2017: 4573756.
|
14. |
Shi T, Min M, Sun C, et al. A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. Sleep Breath, 2019, 23(4): 1047-1057.
|
15. |
刘小丽, 罗倩, 黄玉蓉. 阻塞性睡眠呼吸暂停与尿酸水平相关性分析. 兵团医学, 2019(4): 5-7.
|
16. |
郭世放. 阻塞性睡眠呼吸暂停低通气综合征肾功能损害的危险因素研究. 郑州大学, 2017.
|
17. |
Tada T, Kusano KF, Ogawa A, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant, 2007, 22(4): 1190-1197.
|
18. |
李建锋, 栾煜, 秦海强. 心血管疾病绝对风险评估循证医学指南. 中国卒中杂志, 2009, 4(8): 683-686.
|
19. |
李慧敏, 熊梦清, 胡克, 等. 阻塞性睡眠呼吸暂停患者血清尿酸水平与心血管事件的相关性. 国际呼吸杂志, 2018, 38(6): 449-453.
|
20. |
Jujo K, Minam Y, Haruki S, et al. Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. ESC Heart Fail, 2017, 4(4): 545-553.
|
21. |
Lan Q, Zheng L, Zhou X, et al. The value of blood urea nitrogen in the prediction of risks of cardiovascular disease in an older population. Front Cardiovasc Med, 2021, 8: 614117.
|